Role of retinal detachment subretinal fluid on extracellular matrix metabolism

Ophthalmologica

Volumn 218, Issue 1, 2004, Pages 49-56

  González Avila, Georgina ^a   Méndez, David ^b   Lozano, David ^b   Ramos, Carlos ^a   Delgado, Javier ^a   Iturria, Cecilia ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES RESPIRATORIAS   (Mexico)

^b INSTITUTE OF OPHTHALMOLOGY CONDE DE VALENCIANA   (Mexico)

Author keywords

Collagen; Matrix metalloproteinases; Proliferative vitreoretinopathy; Retinal detachment; Subretinal fluid; Tissue inhibitors of metalloproteinases; Transforming growth factor

Indexed keywords

GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; TRANSFORMING GROWTH FACTOR BETA2;

ADOLESCENT; ADULT; AGED; ARTICLE; CATALYSIS; CATALYST; CELL PROLIFERATION; CLINICAL ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME IMMUNOASSAY; ENZYME METABOLISM; EXTRACELLULAR MATRIX; HUMAN; ISOTOPE LABELING; LUNG FIBROBLAST; QUANTITATIVE ASSAY; RETINA DETACHMENT; SCHOOL CHILD; SUBRETINAL FLUID; ZYMOGRAPHY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY FLUIDS; CHILD; COLLAGENASES; EXTRACELLULAR MATRIX; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; RETINA; RETINAL DETACHMENT; RETINAL PERFORATIONS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA2;

EID: 0347416968     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074567     Document Type: Article

References (30)

1. Chignell AH, Carruthers M, Rahi AHS: Clinical, biochemical and immunoelectrophoretic study of subretinal fluid. Br J Ophthalmol 1971;55:525-532.
2. The Retina Society Terminology Committee: The classification of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1983;90:12-125.
3. Machemer R, Aaberg TM, Feeman HM, Irvine AR, Lean JS, Michels RM: An update classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol 1991;112:159-165.
4. Scheiffarth F, Kampik A, Günther H, von der Mark K: Proteins of the extracellular matrix in vitreoretinal membranes. Graefes Arch Clin Exp Ophthalmol 1988;226:357-361.
5. Wiedemann P, Heimann K: Proliferative vitreoretinopathy. Curr Opin Ophthalmol 1992;3:357-365.
6. Hiscott P, Sheridan C, Magee RM, Grierson I: Matrix and the retinal pigment epithelium in proliferative retinal disease. Prog Retin Eye Res 1999;18:167-190.
7. Immonen I, Konttinen YT, Sorsa T, Tomilla P, Sirén V: Proteinases in subretinal fluid. Graefes Arch Clin Exp Ophthalmol 1996;234:105-109.
8. Kon CH, Occleston NL, Charteries D, Daniels J, Anylward GW, Khaw PT: A prospective study of matrix metalloproteinases in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1998;39:1524-1529.
9. Stetler-Stevenson WG: Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148:1345-1350.
10. Murphy G, Stanton H, Cowel S, Butler G, Knäuper V, Atkinson S, Gavrilovic J: Mechanisms for pro matrix metalloproteinase activation. APMIS 1999;107:38-44.
11. Vu TH, Werb Z: Matrix metalloproteinases: Effectors of development and normal physiology. Genes Dev 2000;14:2123-2133.
12. Denhardt DT, Feng B, Edwards DR, Cocuzzi ET, Malyankar UM: Tissue inhibitor of metalloproteinases (TIMP, aka EPA): Structure, control of expression and biological functions. Pharmacol Ther 1993;59:329-341.
13. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP: Tissue inhibitors of metalloproteinases: Structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-122.
14. Bradford MM: A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
15. 14C-labeled soluble collagen as substrate. Biochim Biophys Acta 1976;445:753-762.
16. Miller EJ, Rhodes RK: Preparation and characterization of the different types of collagen. Methods Enymol 1982;82:33-64.
17. Lefevere MF, Siegers GA, Glaeys AE: Evaluation of a rapid, sensitive and specific assay for the determination of collagenolytic activity in biological samples. Clin Chim Acta 1979;92:167-175.
18. Sunada H, Nagai Y: A rapid microassay method for gelatinolytic activity using tritium-labeled heat-denatured polymeric collagen as a substrate and its application to the detection of enzymes involved in collagen metabolism. J Biochem 1980;87:1765-1772.
19. Vadillo-Ortega F, González-Avila G, Furth EE, Lei H, Muschel RJ, Stetler-Stevenson WG, Strauss JF III: 92 kD type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am J Pathol 1995;146:148-156.
20. Selman M, Gonzalez G, Bravo M, Lopez S, Ramos C, Montaño M, Barquin N, Vadillo F: Effect of lung T lymphocytes on fibroblasts in idiopathic pulmonary fibrosis and extrinsic allergic alveolitis. Thorax 1990;45:451-455.
21. Plantner JJ, Smine A, Quinn TA: Matrix metalloproteinases and metalloproteinase inhibitors in human interphotoreceptor matrix and vitreous. Curr Eye Res 1998;17:132-140.
22. Brown D, Hamdi H, Bahri S, Kenney MC: Characterization of an endogenous metalloproteinase in human vitreous. Curr Eye Res 1998;13:639-647.
23. Webster L, Chignell AH, Limb GA: Predominance of MMP-1 and MMP-2 in epiretinal and subretinal membranes of proliferative vitreoretinopathy. Exp Eye Res 1999;68:91-98.
24. Pederson JE, Cantrill HL: Experimental retinal detachment. V. Fluid movement through the retinal hole. Arch Ophthalmol 1984;102:136-139.
25. Stetler-Stevenson WG: Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention. J Clin Invest 1999;103:1237-1241.
26. Coker RK, Laurent GJ: Pulmonary fibrosis: Cytokines in the balance. Eur Respir J 1998;11:1218-1221.
27. Nagasaki H, Shinagawa K: Risk factors for proliferative vitreoretinopathy. Curr Opin Ophthalmol 1995;6:70-75.
28. González-Avila G, Lozano D, Manjarrez ME, Ruiz MV, Teran L, Vadillo-Ortega F, Selman M: Influence on collagen metabolism of vitreous from eyes with proliferative vitreoretinopathy. Ophthalmology 1995;102:1400-1405.
29. Girard Ph, Mimoun G, Karpouzas Y, Montefiore G: Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery. Retina 1994;14:417-424.
30. Pena RA, Jerdan JA, Glaser BM: Effects of TGF-β and TGF-β neutralizing antibodies on fibroblast-induced collagen gel contraction: Implications for proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1994;35:2804-2808.